HCV Models of Care – Moving Towards Elimination (2)
Thursday 16 December 2021
The Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT)*, in partnership with the World Health Organization Regional Offices for the Western Pacific and South-East Asia, will host a webinar "HCV Models of Care – Moving Towards Elimination (2)".
Date: 16 December 2021
Time: 08:30 Geneva I 13:00 New Delhi I 14:30 Bangkok, Phnom Penh, Viet Nam I 15:30 Kuala Lumpur, Manila
As the world continues to battle the COVID-19 pandemic in 2020-2021, countries with high HCV disease burden are working hard to ensure that HCV care disruption is minimised and those most in need have access to care and services. There are government and community actors responding to the needs of people living with HCV, and much more can be learnt from them to inform our response towards achieving the HCV elimination goal in 2030.
This is the second webinar of the Hepatitis C PACT Webinar Series: Hepatitis C Elimination Strategies. It aims to highlight some of the models of care in HCV management from Viet Nam, Cambodia and Thailand, and contribute to the discussion for HCV elimination by 2030.
More details about the event are available in the attached flyer below.
Moderator: Dr Po-Lin Chan, Acting Team Lead HIV, Viral Hepatitis, STI, WHO Regional Office for the Western Pacific
Speaker 1: HCV are for PLHIV in the country: The Viet Nam Model - Dr Nguyen Huu Hai, Deputy Head, Treatment and Care Department, Viet Nam Authority of HIV/AIDS Control (VAAC), Ministry of Health Viet Nam
Speaker 2: HCV Model of Care in Cambodia: Simplification towards elimination - Dr Keo Samley, Senior Officer, Communicable Disease Control Department & Secretariat of Viral Hepatitis, Ministry of Health, Cambodia
Speaker 3: Phetchabun Project for Elimination of Hepatitis C in Thailand by 2030: An overview - Prof Dr Yong Poovorawan, Faculty of Medicine, Chulalongkorn University, Thailand
* The Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT) is a joint collaboration of Médecins Sans Frontières (MSF); Drugs for Neglected Diseases initiative (DNDi); FIND, the global alliance for diagnostics; and Treatment Action Group (TAG).